3 years ago
MRNA
AnalystsEmmanuel PapadakisEmmanuel Papadakis's Stock Forecasts
AnalystsEmmanuel Papadakis
Analyst Ranking
Bottom 23%
#3794 out of 4871 analysts
Average Return
-4.08%
Win Rate
38%3 out of 8
Risk vs Reward
Poor
Good
Emmanuel Papadakis's 5 best and worst ratings
Emmanuel Papadakis Analyst Color
Get additional color on Emmanuel Papadakis's coverage of popular stocks
Emmanuel Papadakis's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Biontech SeBNTX | 9 | Strong Buy | $150.00 | +42.94% | Maintains | 7 months ago |
Moderna IncMRNA | 6 | Hold | $80.00 | +189.75% | Upgrades | 9 months ago |
AlvotechALVO | 2 | Hold | $12.00 | N/A | Maintains | 2 years ago |
SanofiSNY | 3 | Hold | N/A | N/A | Upgrades | 3 years ago |
Curevac NvCVAC | 1 | Hold | $35.00 | N/A | Initiates Coverage On | 4 years ago |
Novartis AgNVS | 4 | Strong Sell | N/A | N/A | Downgrades | 4 years ago |
Argenx SeARGX | 1 | Hold | N/A | N/A | Initiates Coverage On | 4 years ago |
Ucb SaUCBJY | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Roche Holding LtdRHHBY | 1 | Strong Buy | N/A | N/A | Upgrades | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.